| # | Drug | Count |
|---|---|---|
| 0 | IDURSULFASE | 4 |
| 1 | CYCLOPHOSPHAMIDE | 3 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3 |
| 4 | DASATINIB | 3 |
| 5 | HYDROXYUREA | 3 |
| 6 | IMATINIB | 3 |
| 7 | TEMOZOLOMIDE | 3 |
| 8 | AFATINIB | 2 |
| 9 | DACTINOMYCIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDURSULFASE | 4 | 0.0010 |
| 1 | DACTINOMYCIN | 2 | 0.0009 |
| 2 | DASATINIB | 3 | 0.0003 |
| 3 | AFATINIB | 2 | 0.0003 |
| 4 | TEMOZOLOMIDE | 3 | 0.0001 |
| 5 | HYDROXYUREA | 3 | 0.0001 |
| 6 | RIFAMPICIN | 1 | 0.0001 |
| 7 | IFOSFAMIDE FOR INJECTION | 2 | 0.0001 |
| 8 | LAMIVUDINE | 2 | 0.0001 |
| 9 | SIROLIMUS | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 4 | 0.0003 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 6 | 0.0000 |
| 8 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |